Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03156114
Title	This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Boehringer Ingelheim
Indications	Advanced Solid Tumor lung non-small cell carcinoma follicular lymphoma
Therapies	Ezabenlimab Miptenalimab
Age Groups:	adult \| senior
Covered Countries	USA \| POL \| GBR \| ESP \| CAN